Of the various isoforms of CD44, the two isoforms, CD44s and CD44v6, have been studied in regard to their roles as biomarkers for bladder cancers [39], gastric adenocarcinoma, and colorectal adenocarcinoma [40]. The gene discussed is CD44; the disease is urinary bladder cancer.